4.8 Article

Two step promotion of a hot tumor immune environment by gold decorated iron oxide nanoflowers and light-triggered mild hyperthermia

期刊

NANOSCALE
卷 13, 期 44, 页码 18483-18497

出版社

ROYAL SOC CHEMISTRY
DOI: 10.1039/d1nr03201a

关键词

-

资金

  1. ANR CARGOLD [ANR-16-CE09-0026]
  2. European Union's Horizon 2020 Research and Innovation Program [685795, 801305]
  3. IdEx Universite de Paris [ANR-18-IDEX-0001]
  4. Region Ile de France under the Convention SESAME 2019 - IVETh [EX047011]
  5. French Ligue Nationale Contre le Cancer (Equipes Labellisees)
  6. Plan Cancer (Tumor Heterogeneity and Ecosystem Program)
  7. CARPEM (Cancer Research for Personalized Medicine)
  8. PD fellowship by the Institute Thematique Multi-Organismes (ITMO) Cancer
  9. Doctoral School Frontieres du Vivant (FdV) - Programme Bettencourt
  10. Fondation ARC pour la recherche sur le cancer
  11. Agence Nationale de la Recherche (ANR) [ANR-16-CE09-0026] Funding Source: Agence Nationale de la Recherche (ANR)

向作者/读者索取更多资源

This study reveals that gold decorated iron oxide nanoflowers (GIONF) can significantly impact the tumor immune environment, promoting recruitment of monocytes and creating a pro-inflammatory anti-tumor microenvironment. Furthermore, mild hyperthermia treatment also leads to an increase in CD8+ T lymphocytes and pro-inflammatory cytokines in addition to GIONF effects.
Nanoparticle-mediated photothermal therapy (PTT) is an emerging modality to treat tumors with both spatial and temporal control provided by light activation. Gold decorated iron oxide nanoflowers (GIONF) are good candidates for PTT due to their biocompatibility, biodegradability and light-to-heat conversion. Profound changes in the tumor immune environment might be early induced by the gold and iron oxide metallic agents in addition to the photothermal effects. This study aims to elucidate the outcome of GIONF on their own, and of GIONF-induced mild hyperthermia in the tumor immune infiltrate in a murine model of triple negative breast cancer. First we explored the effects of 24 h GIONF exposure on bone-marrow derived macrophages (BMDM), revealing significant effects on the BMDM phenotype and secretion, 6 days post-incubation, with important downregulation of several cytokines and MHCII expression, predominantly towards a pro-inflammatory response. Intratumoral administration of GIONF promoted an increase in monocyte recruitment at day 1 post-administration, shifting towards a pro-inflammatory anti-tumor microenvironment with lower Treg population and a 4 fold lower CD4/CD8 ratio compared to the control at day 12. On top of the GIONF effects, mild hyperthermia (43 degrees C for 15 min), although it does not induce significant changes in tumor growth, resulted in an additional increase of CD8+ T lymphocytes and pro-inflammatory cytokines. The combination of a timely controlled immune response to GIONF and to mild hyperthermia could be used as a remotely triggered adjuvant treatment to immunotherapy approaches at the best favorable time-window.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据